Analysis: SRF Limited

NSE:SRF Chemicals - Flourine Market cap: ₹77.5K cr

Growth thesis

SRF Ltd is a global fluorochemicals and specialty chemicals producer with core businesses in refrigerant gases (HFC/HFO), fluoropolymers (PTFE), and performance films. Key segments include Fluorochemicals (65,000+ metric ton HFC capacity), Performance Films (BOPET/BOPP/BOPA), and Technical Textiles. Growth will accelerate from INR2,300 crore Odisha capex expanding HFO capacity to 20,000 metric tonnes by FY28, 30,000 tonnes HF integration, and Chemours fluoropolymer projects. Margin expansion is targeted via backward integration, with operational leverage from 180-crore BOPA line (Sep 2027) and pharma intermediates scaling to 20% of specialty revenue. Over 2-3 years, HFC-to-HFO transition, Kigali Amendment-driven quota regimes, and BOPET margin recovery from Chinese capacity cuts will drive compounding growth. Key execution risks include Odisha regulatory delays and margin pressures in agrochemicals.

Why is SRF Limited stock rising?

  • Adding a second pharma intermediate plant at Dahej with INR180 crore investment, expected commissioning in 8 months
  • Pipeline for new agrochemical molecules robust; AI development progressing as planned
  • Pharma segment gaining traction; targeting pharma to reach 20% of specialty chemicals from current ~10%
  • New fluoropolymer projects and next-gen refrigerant gases project on track at Odisha site; regulatory clearances applied
  • First stage capex for Odisha site expected in range of INR1,500-2,000 crore

Research report

companyname: SRF Limited ticker: SRF sector: Diversified Chemicals / Industrial Intermediates SRF Limited is a diversified chemicals and materials company incorporated in 1970, majority-owned by KAMA Holdings (50.21%) and run by the founding Bharat Ram family. Chairman and Managing Director Ashish Bharat Ram leads a business with five segments: Specialty Chemicals, Fluorochemicals, Performance Films & Foil, Technical Textiles, and two small textile fabric businesses (Laminated and Coated). In F...

Read the full report →

Catalysts

capex, margin expansion, new product segment

Growth guidance

FY27 Chemicals business growth guided at 15-20% driven by strategic investments and operational improvements

Guidance no_data

Management consistency

mixed

RS rating: 38 Stage: Stage 1

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for SRF Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.
More in Chemicals - Flourine